CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes CLO & Secretary gave up 9,680 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 11,763 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 32,877 shares (to pay taxes)
- 4 Planned sale Director sold 467 shares at an average $195.91 ($91,490)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 467 shares at an average $189.58 ($88,532)
- 4 Other acquisition Chief Financial Officer acquired 8 shares (other)
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Financial Officer acquired 2,381 shares (option exercise)
- 8-K Event Regulation FD disclosure
- 4 Open-market sale Chief Financial Officer sold 1,804 shares at $188.31 ($339,711)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,862 shares (to pay taxes)
- 4 Option exercise Director acquired 2,034 shares (option exercise)
- 4 Gift Chief Executive Officer gave 130 shares (gift)
- 4 Planned sale Director sold 467 shares at an average $195.84 ($91,457)
- 144 Insider Sale of Securities
Page 6 of 115 · 2,300 filings